Evaxion A (EVAX) Other Non-Current Assets (2019 - 2025)
Evaxion A posted quarterly Other Non-Current Assets of $185000.0 for Q4 2025, up 14.2% year-on-year from $162000.0 in Q4 2024, and little changed on a QoQ basis from $185000.0 in Q2 2025.
Evaxion A (EVAX) has 7 years of Other Non-Current Assets data on file, last reported at $185000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets rose 14.2% year-over-year to $185000.0; the trailing twelve-month figure through Dec 2025 stood at $185000.0 (up 14.2% YoY), and the FY2025 full-year result was $185000.0, up 14.2% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $185000.0, roughly flat from $185000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $200000.0 in Q2 2021 and bottomed at $148000.0 in Q2 2022.
- The 5-year median for Other Non-Current Assets is $167000.0 (2023), against an average of $175076.9.
- The widest annual swing landed in 2022, when Other Non-Current Assets dropped 26.0%; it then advanced 14.2% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $191000.0 in 2021, then decreased by 18.32% to $156000.0 in 2022, then advanced by 7.05% to $167000.0 in 2023, then decreased by 2.99% to $162000.0 in 2024, then increased by 14.2% to $185000.0 in 2025.
- The last three Other Non-Current Assets figures came in at $185000.0 (Q4 2025), $185000.0 (Q2 2025), and $162000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 4.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 185,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Dec 31, 2023 | 167,000.00 |
| Jun 30, 2023 | 165,000.00 |
| Dec 31, 2022 | 156,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 165,000.00 |
| Dec 31, 2021 | 191,000.00 |
| Sep 30, 2021 | 194,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 193,000.00 |
| Dec 31, 2020 | 238,000.00 |
| Dec 31, 2019 | 25,000.00 |